Why is Clinitech Lab falling/rising?

As of 15-Sep, Clinitech Laboratory Ltd's stock price is currently at 46.04, showing no change (0.00%). The stock has experienced a significant decline of 15.52% over the past week and a year-to-date drop of 41.62%. Today's price summary indicates that the stock's performance is inline with its sector, but it is currently higher than the 50-day moving average while being lower than the 5-day, 20-day, 100-day, and 200-day moving averages. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 73.68% against the 5-day average. Unfortunately, there is no information available regarding positive or negative factors impacting the stock.
In the broader market context, Clinitech's recent performance contrasts sharply with the benchmark Sensex, which has gained 1.24% over the past week and 4.67% year-to-date. This indicates that while the broader market is experiencing upward momentum, Clinitech is lagging significantly behind, reflecting investor concerns and a lack of confidence in the stock's prospects. The stark difference in returns suggests that market sentiment is not favorable for Clinitech at this time, contributing to its ongoing price stagnation.